Etoposide‐related secondary acute myeloid leukemia (t‐AML) in hemophagocytic lymphohistiocytosis
- 25 October 2006
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (2) , 121-123
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignanciesJournal of Medical Genetics, 2006
- High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adultsPediatric Blood & Cancer, 2005
- Treatment of Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH) in young adults: A report from the HLH studyl centerMedical and Pediatric Oncology, 2003
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantationBlood, 2002
- Quantitative Analysis of Cell-free Epstein-Barr Virus Genome Copy Number in Patients with EBV-associated Hemophagocytic LymphohistiocytosisLeukemia & Lymphoma, 2002
- Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosisMedical and Pediatric Oncology, 2001
- Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)Leukemia & Lymphoma, 2000
- Therapy‐related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risksMedical and Pediatric Oncology, 1994
- Myelodysplasia Syndrome Following Epipodophyllotoxin Therapy in Familial HemophagocyticlymphohistiocytosisPediatric Hematology and Oncology, 1993
- Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1991